Q/C Technologies, Inc. Increase (Decrease) in Operating Liabilities
Q/C Technologies, Inc. (QCLS) reported Increase (Decrease) in Operating Liabilities of $37 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2020-11-16
- Q/C Technologies, Inc. increase (decrease) in operating liabilities for the quarter ending 2020-09-30 was -$39.00.
- Q/C Technologies, Inc. increase (decrease) in operating liabilities for the quarter ending 2020-06-30 was -$1.05K.
- Q/C Technologies, Inc. increase (decrease) in operating liabilities for the quarter ending 2020-03-31 was $1.13K.
| Period end | Increase (Decrease) in Operating Liabilities 3 month | Increase (Decrease) in Operating Liabilities 6 month | Increase (Decrease) in Operating Liabilities 9 month |
|---|---|---|---|
| 2020-09-30 | -$39.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$1.09K derived: sum of 2 quarters · filed 2020-11-16 | $37.00 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$1.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $76.00 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.13K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |